Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (5): 892-896. doi: 10.19723/j.issn.1671-167X.2020.05.016
Previous Articles Next Articles
Qian GUO1,2*,Xiao-xu MA1*,Hui GAO2,Lian-jie SHI2,Yu-chao ZHONG1,Lin-feng XIE1,Miao SHAO1,Xue-wu ZHANG1,∆()
CLC Number:
[1] |
Sarris M, Andersen KG, Randow F, et al. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition[J]. Immunity, 2008,28(3):402-413.
doi: 10.1016/j.immuni.2008.01.012 |
[2] |
Ji JD, Park-Min KH, Ivashkiv LB. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages[J]. Hum Immunol, 2009,70(4):211-217.
doi: 10.1016/j.humimm.2009.01.026 |
[3] |
Lepelletier Y, Moura IC, Hadj-Slimane R, et al. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization[J]. Eur J Immunol, 2006,36(7):1782-1793.
doi: 10.1002/eji.200535601 pmid: 16791896 |
[4] |
Catalano A, Caprari P, Moretti S, et al. Semaphorin 3A is expressed by tumor cells and alters T-cell signal transduction and function[J]. Blood, 2006,107(8):3321-3329.
doi: 10.1182/blood-2005-06-2445 pmid: 16380453 |
[5] |
Vadasz Z, Haj T, Halasz K, et al. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus[J]. Arthritis Res Ther, 2012,14(3):R146.
doi: 10.1186/ar3881 pmid: 22697500 |
[6] |
Sturrock RD. Hematologic disorders in rheumatic disease[J]. Curr Opin Rheumatol, 1991,3(1):172.
doi: 10.1097/00002281-199102000-00024 pmid: 2043444 |
[7] |
Kashiwagi H, Shiraga M, Kato H, et al. Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A[J]. Blood, 2005,106(3):913-921.
doi: 10.1182/blood-2004-10-4092 pmid: 15831706 |
[8] | 高辉, 马晓旭, 郭倩, 等. Sema3A在系统性红斑狼疮患者血清及单个核细胞中的表达[J]. 中华医学杂志, 2017,97(5):370-374. |
[9] |
Okuno T, Nakatsuji Y, Kumanogoh A. The role of immune semaphorins in multiple sclerosis[J]. FEBS Lett, 2011,585(23):3829-3835.
doi: 10.1016/j.febslet.2011.03.033 |
[10] |
Eixarch H, Gutierrez-Franco A, Montalban X, et al. Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis[J]. Trends Mol Med, 2013,19(3):157-164.
doi: 10.1016/j.molmed.2013.01.003 pmid: 23419749 |
[11] |
Takagawa S, Nakamura F, Kumagai K, et al. Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis[J]. BMC Musculoskelet Disord, 2013,14:40.
doi: 10.1186/1471-2474-14-40 pmid: 23343469 |
[12] |
Kuwana M, Kawakami Y, Ikeda Y. Suppression of autoreactive T-cell response to glycoprotein Ⅱb/Ⅲa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura[J]. Blood, 2003,101(2):621-623.
doi: 10.1182/blood-2002-07-2157 pmid: 12393517 |
[13] |
Shenoy S, Mohanakumar T, Chatila T, et al. Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias[J]. Clin Immunol, 2001,99(2):266-275.
doi: 10.1006/clim.2001.5017 |
[14] |
Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chro-nic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response[J]. Blood, 2004,103(7):2645-2647.
doi: 10.1182/blood-2003-07-2268 pmid: 14670926 |
[15] |
Ling Y, Cao X, Yu Z, et al. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome [J]. Eur J Haematol, 2007,79(4):310-316.
doi: 10.1111/j.1600-0609.2007.00917.x pmid: 17692100 |
[16] |
Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura[J]. Nat Med, 2003,9(9):1123-1124.
doi: 10.1038/nm921 pmid: 12937414 |
[17] |
Wannemacher KM, Wang L, Zhu L, et al. The role of sema-phorins and their receptors in platelets: Lessons learned from neuronal and immune synapses[J]. Platelets, 2011,22(6):461-465.
doi: 10.3109/09537104.2011.561891 |
[1] | Jia-yi TIAN,Xia ZHANG,Gong CHENG,Qing-hong LIU,Shi-yang WANG,Jing HE. Serum interleukin-2 receptor α as a clinical biomarker in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1083-1087. |
[2] | Jian-mei ZOU,Li-jun WU,Cai-nan LUO,Ya-mei SHI,Xue WU. Relationship of serum 25- hydroxy vitamin D and systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 938-941. |
[3] | Zheng-fang LI,Xue WU,Li-jun WU,Cai-nan LUO,Ya-mei SHI,Yan ZHONG,Xiao-mei CHEN,Xin-yan MENG. Clinical features of patients with Rhupus syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 933-937. |
[4] | MA Xiang-bo,ZHANG Xue-wu,JIA Ru-lin,GAO Ying,LIU Hong-jiang,LIU Yu-fang,LI Ying-ni. Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 721-727. |
[5] | XIA Fang-fang,LU Fu-ai,LV Hui-min,YANG Guo-an,LIU Yuan. Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 266-272. |
[6] | Jing ZHAO,Feng SUN,Yun LI,Xiao-zhen ZHAO,Dan XU,Ying-ni LI,Yu-hui LI,Xiao-lin SUN. Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1009-1013. |
[7] | Yan GENG,Bo-rui LI,Zhuo-li ZHANG. Musculoskeletal ultrasound findings of symptomatic joints in patients with systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 163-168. |
[8] | Ying-ni LI,Xiao-hong XIANG,Jing ZHAO,Yun LI,Feng SUN,Hong-yan WANG,Ru-lin JIA,Fan-lei HU. Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1019-1024. |
[9] | Yu-hua WANG,Guo-hua ZHANG,Ling-ling ZHANG,Jun-li LUO,Lan GAO. Adrenal hemorrhage in a patient with systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1178-1181. |
[10] | Hong-lin ZHU,Qian DU,Wei-lin CHEN,Xiao-xia ZUO,Quan-zhen LI,Si-jia LIU. Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 716-722. |
[11] | Jiao YANG,Hai-hong YAO,Xiao-dong MO,Zeng LUO,yang-jin Bai-ma. Clinical and immunological characteristics of patients with systemic lupus erythematosus in Tibet plateau, China [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1004-1008. |
[12] | Xiao-hui ZHANG,Xue-rong DENG,Fan Li,Ying ZHU,Zhuo-li ZHANG. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case report [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1102-1107. |
[13] | Shuang LIU,Yu-long GUO,Jing-yi YANG,Wei WANG,Jian XU. Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1014-1021. |
[14] | Fan YANG,Yun-shan ZHOU,Yuan JIA. Systemic lupus erythematosus with acquired hemophilia A: a case report [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1108-1111. |
[15] | Yu-bing XIAO,Mu-yao GUO,Xiao-xia ZUO. Immunometabolism and systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1120-1124. |